Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.845 USD | -1.86% |
|
+14.60% | -91.85% |
Jul. 08 | Aerovate Therapeutics to Explore Strategic Alternatives | CI |
Jul. 08 | Aerovate Therapeutics to Explore Strategic Alternatives After Hypertension Trial Shutdown | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-91.85% | 54.19M | |
+23.20% | 47.07B | |
+46.45% | 42.06B | |
-2.85% | 39.98B | |
+37.47% | 33.02B | |
-6.30% | 27.9B | |
+19.35% | 27.63B | |
+47.67% | 14.37B | |
+43.57% | 13.45B | |
+0.79% | 12.03B |
- Stock Market
- Equities
- AVTE Stock
- News Aerovate Therapeutics, Inc.
- Aerovate Therapeutics to Explore Strategic Alternatives After Hypertension Trial Shutdown